DCP Logo
  • Home
  • About
    • DCP program
    • DCP program history
    • Structural Genomic Consortium
    • Probe contributions
  • Show Probes
    • All
    • Kinase
    • GPCR
    • Ion channel
    • Epigenetics
    • Other enzymes
    • Other targets
  • Order set
  • Download
  • Information
    • FAQ
    • Probe resources
    • Donate probes
    • Contact
    • Funding
    • Update history
All probes Probe criteria Further information Usage Order Properties Structure Compound analysis Potency Selectivity Data download
  • Probe criteria
  • Further information
  • Usage
  • Order
  • Properties
  • Structure
  • Compound analysis
  • Potency
  • Selectivity
  • Data download

Usage recommendations for probe MSD-CYP11B2 and control MSD-CYP11B2 Negative control


In cells

Recommended dosing is up to IC90 ~  25-100 nM.

Use the recommended concentration to avoid off-target toxicity and/or off-target activity. Using concentrations that are higher than recommended could lead to false positive or confounding results.

In vivo

Good pharmacokinetic profile in rat and rhesus. Tested in rhesus model: IV infusions with up to 0.3 mg/kg, but also suitable for oral dosing; produces significant reductions in rhesus plasma aldosterone levels with no apparent effect on cortisol levels.